Jung‐Yoon Choe

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis

Brad H. Rovin, Neil Solomons, William F. Pendergraft et al. · Kidney International · 2018 · 290 citations

Dose-ranging Voclosporin, Glomerulonephritis, Autoimmune Disease +12

High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry

Celi Sun, Julio E. Molineros, Loren L. Looger et al. · Nature Genetics · 2016 · 262 citations · Full text

Genome-wide Association Study, Autoimmune Disease, Medicine +13

Interleukin 1 Receptor Dependence of Serum Transferred Arthritis Can be Circumvented by Toll-like Receptor 4 Signaling

Jung‐Yoon Choe, Brian Crain, Sarah R. Wu et al. · The Journal of Experimental Medicine · 2003 · 188 citations · Full text

A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy

Jung‐Yoon Choe, Nenad Prodanović, Jaroslaw Niebrzydowski et al. · Annals of the Rheumatic Diseases · 2015 · 165 citations · Full text